Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

YJUN vs XJUN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

XJUN Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–0 Matrix Metrics)

XJUN Overall Winner 6-Pillar Tally: YJUN 0 – 0 XJUN (6 Tie) Matrix Metrics: YJUN 0 – 2 XJUN

As of Nov 16, 2026, FT Vest U.S. Equity Enhance & Moderate Buffer ETF - June (XJUN) is the stronger overall head-to-head candidate over FT Vest International Equity Moderate Buffer ETF - June (YJUN) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). YJUN carries a Unified Composite Score of 50.4/100 (HOLD) at $26.85 (N/M Forward P/E, N/A operating margin), whereas XJUN carries 57.5/100 (HOLD) at $44.88 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: YJUN is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.3); meanwhile XJUN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About YJUN vs XJUN
YJUN Cboe BZX
FT Vest International Equity Moderate Buffer ETF - June
Institutional Equity
$26.85
-0.5% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.40β · 10% Vol
Unified Composite Score
50.4 / 100 HOLD
Tech 49.0 Fund 52.0 Flow 50.0 Mom 58.9
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.8%) with fading momentum, RSI 46
RSI-14: 46.3 · SMA20: $26.95 · SMA50: $27.02
XJUN Cboe BZX Head-to-Head Winner
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - June
Institutional Equity
$44.88
-0.99% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.31β · 10% Vol
Unified Composite Score
57.5 / 100 HOLD
Tech 49.0 Fund 60.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 41
RSI-14: 41.3 · SMA20: $45.35 · SMA50: $45.38

6-Pillar Scorecard Institutional Category Breakdown (YJUN 0 – 0 XJUN)

Columns: Metric · YJUN · XJUN
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: YJUN (0) vs XJUN (2)
Institutional Metric YJUN XJUN Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
72% ($25–$28) 75% ($42–$46) Stronger Trend XJUN
Beta / 30D Volatility
Risk Regime
0.40β · 10% Vol 0.31β · 10% Vol Lower Realized Risk Tie
Unified Institutional Score
Composite Signal
50.4 / 100 (HOLD) 57.5 / 100 (HOLD) Higher Composite XJUN
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon YJUN +0.95 pp
YJUN: -0.23% · XJUN: -1.18%
3M Horizon XJUN +1.55 pp
YJUN: -2.1% · XJUN: -0.55%
6M Horizon XJUN +0.75 pp
YJUN: +0.8% · XJUN: +1.55%
1Y Horizon YJUN +0.37 pp
YJUN: +6.41% · XJUN: +6.04%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on YJUN vs XJUN. Trailing 12-month operating profitability (YJUN N/A vs XJUN N/A) and valuation multiples (YJUN N/M vs XJUN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

YJUN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
XJUN ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
YJUN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact YJUN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XJUN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XJUN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
YJUN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
XJUN Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ YJUN vs XJUN Key Questions & Quantitative Answers

As of Nov 16, 2026, FT Vest U.S. Equity Enhance & Moderate Buffer ETF - June (XJUN) is the stronger overall head-to-head candidate over FT Vest International Equity Moderate Buffer ETF - June (YJUN) in the Tradestie Institutional Equity Comparison Engine, winning 2–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). YJUN carries a Unified Composite Score of 50.4/100 (HOLD) at $26.85 (N/M Forward P/E, N/A operating margin), whereas XJUN carries 57.5/100 (HOLD) at $44.88 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: YJUN is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.3); meanwhile XJUN is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

YJUN and XJUN split Growth & Scale metrics: YJUN posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XJUN at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, YJUN generates N/A in USD-normalized revenue versus N/A for XJUN. In operating R&D and SG&A reinvestment, YJUN deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XJUN.

YJUN and XJUN trade at balanced relative valuation multiples. YJUN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XJUN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against YJUN (N/A ROE) versus XJUN (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, YJUN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.40β · 10% Vol realized risk). By comparison, XJUN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.31β · 10% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

FT Vest International Equity Moderate Buffer ETF - June (YJUN) Research Suite

FT Vest U.S. Equity Enhance & Moderate Buffer ETF - June (XJUN) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.